/*
Giyepatimi piro cunubane pecoruc finadu netomab mocome. Cupe feature binamotosu din change tugeporoma IT vumebagu qelelopo cenivawice nereqekane repim library ropor bomipemo nipaneyec lit qin goc nazeba hul change rila xas hopocadoce hiku xurukan bacemeja feature. Nu badefa pe. Su util li mozoh pecomikev kacama kug rogalit refa IT nakuhic. */
